Patents Assigned to Augmenta Biologicals, LLC
  • DELIVERY PROTEINS
    Publication number: 20130115230
    Abstract: Disclosed herein are materials and methods related to vaccines. Materials and methods for delivery of a payload, e.g., an immunogen, to the reticuloendothelial system via non-circulating lymphoid cells are provided.
    Type: Application
    Filed: April 29, 2011
    Publication date: May 9, 2013
    Applicant: Augmenta Biologicals, LLC
    Inventor: Paul M. Simon
  • TARGETED IMMUNE CONJUGATES
    Publication number: 20130071413
    Abstract: Disclosed herein are materials and methods related to vaccines. Materials and methods for delivery of immunogens to the reticuloendothelial system via non-circulating lymphoid cells are provided.
    Type: Application
    Filed: August 22, 2012
    Publication date: March 21, 2013
    Applicant: AUGMENTA BIOLOGICALS, LLC
    Inventor: Paul M. Simon
  • Targeted immune conjugate comprising an antibody to glycophorin A and a M2e peptide
    Patent number: 8318912
    Abstract: Disclosed herein are materials and methods related to vaccines. Materials and methods for delivery of immunogens to the reticuloendothelial system via non-circulating lymphoid cells are provided.
    Type: Grant
    Filed: June 22, 2007
    Date of Patent: November 27, 2012
    Assignee: Augmenta Biologicals, LLC
    Inventor: Paul M. Simon